60
Participants
Start Date
September 15, 2024
Primary Completion Date
December 15, 2024
Study Completion Date
February 1, 2025
Liposomal bupivacaine plus bupivacaine
Liposomal bupivacaine is a prolonged-release formulation of the local anesthetic bupivacaine. This intervention involves the administration of liposomal bupivacaine plus bupivacaine as a local anesthetic for the pericapsular nerve group (PENG) block under ultrasound guidance. Liposomal bupivacaine is being investigated for its analgesic effect in postoperative pain management following hip replacement surgery. This formulation is designed to provide extended pain relief as compared to conventional bupivacaine formulations.
Ropivacaine
Ropivacaine is a commonly used local anesthetic in clinical practice, and it serves as the active comparator intervention in this study. Participants in the comparator arm will receive ropivacaine as a local anesthetic for the PENG block under ultrasound guidance.
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, HUST, Wuhan
Huazhong University of Science and Technology
OTHER